{
  "id": "cluster_0_doc5",
  "content": "Medical Tribune article 02/2024 highlights Polk Health Network's gene therapy outcomes. Specialist Dr. Elias Tan remarks: 'Our most complex case involved a patient requiring concurrent neuropathic care and antibody replacement, dramatically improving after 7 months.' Study identifies age 50+ subgroup as highest responders.",
  "metadata": {
    "format": "news_article"
  }
}